Literature DB >> 9113933

Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening.

Y L Lau1, L C Chan, Y Y Chan, S Y Ha, C Y Yeung, J S Waye, D H Chui.   

Abstract

BACKGROUND: The thalassemias are common in southern China. We determined the prevalence of heterozygous carriers of these genetic disorders in Hong Kong and assessed the feasibility of a community-based screening program.
METHODS: An educational and screening program for the thalassemias was carried out in three high schools with a total of 2420 students. Seventy-five percent of the students agreed to undergo screening, which consisted of blood counts, hemoglobin electrophoresis, serum ferritin measurements, and DNA analyses.
RESULTS: Of the 1800 blood samples tested, 150 (8.3 percent) had microcytosis (mean corpuscular volume, <80 microm3). Ninety students (5.0 percent) were carriers of alpha-thalassemia, of whom 81 (4.5 percent) were carriers of the Southeast Asian type of deletion, in which both alpha-globin genes on the same chromosome 16 are deleted. Sixty-one students (3.4 percent) were carriers of either beta-thalassemia or the mutation coding for hemoglobin E. Six students were carriers of both alpha- and beta-thalassemias. On the basis of these figures, the estimated numbers of pregnancies in Hong Kong in which the fetus is at risk for homozygous alpha-thalassemia and beta-thalassemia major or intermedia are 145 and 80 per year, respectively. In Hong Kong the actual numbers of women referred for prenatal diagnoses of these disorders are approximately 95 and 40 per year, respectively.
CONCLUSIONS: Despite the availability of hospital-based screening and prenatal diagnosis for many years in Hong Kong, many women carrying fetuses at risk for thalassemia are not referred for genetic counseling. A community-based program of education, screening, and counseling is needed in Hong Kong and southern China.

Entities:  

Mesh:

Year:  1997        PMID: 9113933     DOI: 10.1056/NEJM199705013361805

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Alpha0 thalassaemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes.

Authors:  S-Q Jia; J Li; Q-H Mo; C Liao; L-Y Li; X-M Xu
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

2.  The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening.

Authors:  X M Xu; Y Q Zhou; G X Luo; C Liao; M Zhou; P Y Chen; J P Lu; S Q Jia; G F Xiao; X Shen; J Li; H P Chen; Y Y Xia; Y X Wen; Q H Mo; W D Li; Y Y Li; L W Zhuo; Z Q Wang; Y J Chen; C H Qin; M Zhong
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

Authors:  Chunming Ding; Rossa W K Chiu; Tze K Lau; Tse N Leung; Li C Chan; Amy Y Y Chan; Pimlak Charoenkwan; Ivy S L Ng; Hai-Yang Law; Edmond S K Ma; Xiangmin Xu; Chanane Wanapirak; Torpong Sanguansermsri; Can Liao; Mary Anne Tan Jin Ai; David H K Chui; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

4.  A laboratory strategy for genotyping haemoglobin H disease in the Chinese.

Authors:  Amy Yuk-Yin Chan; Chi-Chiu So; Edmond Shiu-Kwan Ma; Li-Chong Chan
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

5.  A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression.

Authors:  John J Farrell; Richard M Sherva; Zhi-Yi Chen; Hong-Yuan Luo; Benjamin F Chu; Shau Yin Ha; Chi Kong Li; Anselm C W Lee; Rever C H Li; Chi Keung Li; Hui Leung Yuen; Jason C C So; Edmond S K Ma; Li Chong Chan; Vivian Chan; Paola Sebastiani; Lindsay A Farrer; Clinton T Baldwin; Martin H Steinberg; David H K Chui
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

Review 6.  An international registry of survivors with Hb Bart's hydrops fetalis syndrome.

Authors:  Duantida Songdej; Christian Babbs; Douglas R Higgs
Journal:  Blood       Date:  2017-01-05       Impact factor: 22.113

Review 7.  Hematopoietic stem cell transplantation for people with ß-thalassaemia major.

Authors:  Vanitha A Jagannath; Zbys Fedorowicz; Amani Al Hajeri; Akshay Sharma
Journal:  Cochrane Database Syst Rev       Date:  2016-11-30

Review 8.  Clinical manifestations of α-thalassemia.

Authors:  Elliott P Vichinsky
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 9.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

10.  Comparing prevalence of Iron Deficiency Anemia and Beta Thalassemia Trait in microcytic and non-microcytic blood donors: suggested algorithm for donor screening.

Authors:  Aseem K Tiwari; Iva Chandola
Journal:  Asian J Transfus Sci       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.